CellFE
Latest round
- Series A
Last raised
- Jul 2023
Total raised
- $16M
Investors
- 10
About CellFE
Founded in 2018 in San Carlos, California, CellFE Inc. focuses on biotechnological advancements in cell therapy. The company was established by a team including Alexander Alexeev, Alla Zamarayeva, and Todd Sulchek, with Alla Zamarayeva serving as the CEO.CellFE specializes in advanced microfluidic-based technologies that facilitate the development and delivery of cell therapies. Their flagship product, the CellFE system, is a benchtop device designed to streamline research and process development in cell therapy applications. The technology is engineered to enhance cell health, enable high yields, and support rapid and complex genome editing without the use of viral vectors. CellFE’s solutions primarily target cell therapy researchers and developers aiming to overcome challenges related to scalability, manufacturing costs, and vein-to-vein times, ultimately making lifesaving therapies more accessible to patients.CellFE’s revenue model is based on direct sales of its core products, such as the CellFE system and related technologies, to research institutions, biotech firms, and pharmaceutical companies engaged in cell therapy. Transactions typically involve B2B partnerships, where customers purchase equipment and technology licenses for specific applications in their research or manufacturing processes. Additionally, the company may offer subscription-based access to software or ongoing support services, tailoring their offerings to the unique needs of each client. The structure of these transactions emphasizes long-term relationships, where the value is derived from the effective implementation of CellFE’s technology in clinical and commercial settings.In July 2023, CellFE Inc. Plans include targeting regions with emerging cell therapy initiatives and strengthening its presence in North America and Europe. Specific timelines for these expansions are ongoing as the company assesses market opportunities.
Who invested in CellFE
10 investors across 2 rounds
See all investors in CellFE
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about CellFE
Who invested in CellFE?
CellFE has 10 investors on record across 2 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CellFE raised?
CellFE has raised 2 venture rounds. Sign up free to see how much each round raised and the total.
When did CellFE last raise money?
CellFE's most recent round on record is a Series A, in Jul 2023.
What does CellFE do?
Founded in 2018 in San Carlos, California, CellFE Inc.
Where is CellFE headquartered?
CellFE is headquartered in San Carlos, US.
Which VCs invest in companies like CellFE?
Among active investors with capital left to deploy, Andreessen Horowitz, Founders Fund, Accel and Thrive Capital back biotechnology companies at CellFE's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series A
Raising like CellFE? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.